Fatty liver disease is usually associated with ageing and obesity. However, now it is being observed among children as well ...

New research shows bariatric surgery's powerful impact on liver health, reducing fatty liver disease risk and improving ...

LiverRight™, a Cincinnati-based provider of healthcare services for the U.S. Hepatology and Fatty Liver Disease communities, announced today that the LiverRight Hepatology Clinic has begun treating ...

The Cyprus Association of Liver Patients "Promitheas" launched a new information campaign on Friday, focusing on the risks ...

Right now, patients with obesity and cirrhosis have few treatments for their progressive liver disease, but a new study ...

The most well-known cause of fatty liver is drinking too much alcohol. This condition, called alcoholic fatty liver disease, ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

Akero Therapeutics (AKRO) reported 96-week data in its trial of advanced MASH patients, and there seem really significant ...

A dietary supplement used to build muscle – or prevent muscle loss as a result of ageing or illness – is to be trialled as a potential treatment for chronic liver disease.

By Sriparna Roy (Reuters) -Akero Therapeutics shares gained 106% before the bell on Monday, after its lead drug showed it can ...